Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study [PDF]
Clinical Hypertension, 2022 Background This study evaluated the circadian efficacy of a telmisartan 40 mg/S-amlodipine 2.5 mg fixed-dose combination (Telmisartan40/S-Amlodipine2.5) compared to telmisartan 80 mg (Telmisartan80) in patients with essential hypertension who did not ...
Bong-Joon Kim +10 more
doaj +7 more sources
CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE
Рациональная фармакотерапия в кардиологии, 2016 Contemporary scientific data about mode of action of calcium channel blocker — amlodipine, its pleiotropic effect (influence on endothelial function and antiatherogenic action) is presented.
M. V. Leonova
doaj +3 more sources
Efficacy and tolerability of initial high vs low doses of S-(-)-amlodipine in hypertension. [PDF]
J Clin Hypertens (Greenwich), 2017 In an 8‐week randomized trial of patients with mild or moderate hypertension, the authors investigated the efficacy and tolerability of initial high (5.0 mg/d) vs low (2.5 mg/d) doses of S‐(‐)‐amlodipine (equivalent to 5 and 10 mg of racemic amlodipine, respectively).
Chen Q +6 more
europepmc +4 more sources
Рациональная фармакотерапия в кардиологии, 2015 Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β-blocker, atenolol, in patients with arterial hypertension (HT) 1-2 degree com- pared to fixed combination of racemic amlodipine and atenolol.Material and ...
M. A. Maksimova +2 more
doaj +4 more sources
The dynamics of 24-hour ambulatory blood pressure monitoring parameters, subclinical damage and endothelial function of vessels in patients with arterial hypertension and chronic obstructive pulmonary disease treated with S-amlodipine, Nebivolol and Enala [PDF]
Zaporožskij Medicinskij Žurnal, 2017 Aim of the research was to investigate additional prescription of S-amlodipine or Nebivolol to Enalapril treatment on the 24-h blood pressure monitoring (BPM) parameters, subclinical damage and endothelial function of vessels, and to make of proposing of
O. G. Ivanko +3 more
doaj +5 more sources
S-amlodipine-induced gingival enlargement. [PDF]
Indian J Nephrol, 2015 Vikrant S.
europepmc +3 more sources
S-AMLODIPINE AS A MODERN EFFECTIVE ANTIHYPERTENSIVE AND AN ANTIANGINAL AGENT
Wiadomości Lekarskie, 2023 The aim: Study of the clinical and hemodynamic effects of S-amlodipine in patients with arterial hypertension associated with coronary artery disease, in individuals with preserved LV systolic function. Materials and methods: The study includes 51 patients with arterial hypertension associated with coronary artery disease, who were treated with S ...
Ivan V, Chopei +5 more
openaire +2 more sources
Open Life Sciences, 2021 This research aimed to describe the functions of vascular endothelial cells (VECs) in protecting target organs and the anti-atherosclerotic effects of different enantiomers of amlodipine on a rabbit model of atherosclerosis. Thirty male New Zealand white
Zhang Jing +6 more
doaj +1 more source
Effect of combination treatment of S–amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats [PDF]
, 2014 BACKGROUND: Type 2 diabetes is a complex metabolic disorder characterized by hyperglycemia, impaired glucose tolerance and insulin resistance associated with dyslipidemia and hypertension.
Arvind Semwal +8 more
core +2 more sources
Cyclodextrine Screening for the Chiral Separation of Amlodipine Enantiomers by Capillary Electrophoresis [PDF]
Advanced Pharmaceutical Bulletin, 2015 Purpose: Amlodipine is a long acting, dihydropyridine type calcium channel blocker frequently used in the treatment of hypertension and coronary insufficiency.
Gabriel Hancu +3 more
doaj +1 more source